Literature DB >> 367651

Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms.

D Taylor-Robinson, H U Schorlemmer, P M Furr, A C Allison.   

Abstract

Mouse peritoneal macrophages in culture exposed to Mycoplasma pulmonis show marked biochemical changes. This micro-organism induces the release of hydrolytic enzymes from macrophages. The release is time- and dose-dependent and is not associated with loss of the cytoplasmic enzyme lactate dehydrogenase or any other sign of cell death. Secretory products of macrophages may play a role in the pathogenesis of chronic inflammatory responses elicited by mycoplasma infections. One of the products of activated macrophages is the complement cleavage product C3a. Purified C3a was incubated with M. hominis, M. pulmonis, Proteus mirabilis and an L-phase variant of this organism. All mycoplasmas and the L-phase variant were lysed by low concentrations of C3a, whereas the bacterial form of Pr. mirabilis was resistant.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 367651      PMCID: PMC1537430     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Interactions between Mycoplasma pneumoniae and guinea pig complement.

Authors:  W Bredt; D Bitter-Suermann
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation.

Authors:  H U Schorlemmer; P Davies; W Hylton; M Gugig; A C Allison
Journal:  Br J Exp Pathol       Date:  1977-06

3.  Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

4.  Effects of activated complement components on enzyme secretion by macrophages.

Authors:  H U Schorlemmer; A C Allison
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

5.  Ability of activated complement components to induce lysosomal enzyme release from macrophages.

Authors:  H U Schorlemmer; P Davies; A C Allison
Journal:  Nature       Date:  1976-05-06       Impact factor: 49.962

6.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

7.  Induction of lysosomal enzyme release from cultured macrophages by dextran sulfate.

Authors:  H U Schorlemmer; R Burger; W Hylton; A C Allison
Journal:  Clin Immunol Immunopathol       Date:  1977-01

8.  Purification and partial characterization of human and porcine C3a anaphylatoxin.

Authors:  T E Hugli; E H Vallota; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

9.  The part played by cell-mediated immunity in mycoplasma respiratory infections.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Dev Biol Stand       Date:  1975

10.  Cytolytic effects of the complement cleavage product, C3a.

Authors:  J Ferluga; H U Schorlemmer; L C Baptista; A C Allison
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  11 in total

Review 1.  Immunity to mycoplasma infections of the respiratory tract: a review.

Authors:  G Taylor
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 5.344

2.  Direct activation of the J774.1 Murine macrophage cell line by mycoplasma arthritidis.

Authors:  J N Dietz; B C Cole
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

3.  Mycoplasma polysaccharide protects against complement.

Authors:  Jeffrey R Bolland; Warren L Simmons; James M Daubenspeck; Kevin Dybvig
Journal:  Microbiology       Date:  2012-04-13       Impact factor: 2.777

4.  Interaction of Mycoplasma dispar with bovine alveolar macrophages.

Authors:  R A Almeida; M J Wannemuehler; R F Rosenbusch
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  Neutrophils Induce Astroglial Differentiation and Migration of Human Neural Stem Cells via C1q and C3a Synthesis.

Authors:  Mitra J Hooshmand; Hal X Nguyen; Katja M Piltti; Francisca Benavente; Samuel Hong; Lisa Flanagan; Nobuko Uchida; Brian J Cummings; Aileen J Anderson
Journal:  J Immunol       Date:  2017-07-07       Impact factor: 5.422

6.  Mycoplasma pulmonis inhibits electrogenic ion transport across murine tracheal epithelial cell monolayers.

Authors:  L C Lambert; H Q Trummell; A Singh; G H Cassell; R J Bridges
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

7.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis.

Authors:  B Evengård; K Sandstedt; G Bölske; R Feinstein; I Riesenfelt-Orn; C I Smith
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

9.  Variation in the susceptibility of bovine mycoplasmas to killing by the alternative complement pathway in bovine serum.

Authors:  C J Howard
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

10.  Mycoplasma capricolum membranes induce tumor necrosis factor alpha by a mechanism different from that of lipopolysaccharide.

Authors:  T Sher; S Rottem; R Gallily
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.